Cost of revenue · 2017–2025

Puma Biotechnology cost of revenue

$58.2M−9.7% · FY2025

Puma Biotechnology (PBYI) reported $58.2M in cost of revenue for fiscal 2025, −9.7% year on year.

$5.6M2017$34.6M2018$36.8M2019$39.4M2020$63.7M2021$55.1M2022$62.7M2023$64.4M2024$58.2M2025
Puma Biotechnology — Cost of revenue, 2017–2025
Fiscal yearCost of revenueChangeFiling
FY20252025-12-31$58.2M−9.7%Open →
FY20242024-12-31$64.4M+2.7%Open →
FY20232023-12-31$62.7M+13.8%Open →
FY20222022-12-31$55.1M−13.5%Open →
FY20212021-12-31$63.7M+61.8%Open →
FY20202020-12-31$39.4M+7.0%Open →
FY20192019-12-31$36.8M+6.3%Open →
FY20182018-12-31$34.6M+521.3%Open →
FY20172017-12-31$5.6M—Open →

Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +34.1%

Cost of revenue at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Puma Biotechnology cost of revenue |url=https://companiesranked.com/en/company/puma-biotechnology/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Puma Biotechnology cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/puma-biotechnology/cost-of-revenue

BibTeX

@misc{companiesranked-en-company-puma-biotechnology-cost-of-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Puma Biotechnology cost of revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/puma-biotechnology/cost-of-revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001437749-26-005891 · February 26, 2026

{{cite web |title=Puma Biotechnology cost of revenue — 10-K (0001437749-26-005891) |url=https://www.sec.gov/Archives/edgar/data/1401667/000143774926005891/pbyi20251231_10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Puma Biotechnology overview